Contact Us

TOURISM NEWS

Despite External Challenges, WuXi AppTec Revenue and Profit Continued to Grow QoQ in the First Three Quarters of 2024; the Third Quarter Revenue Back to RMB 10+ Billion, Up 14.6% YoY Excluding COVID-19 Commercial Projects; Backlog Up 35.2% YoY

Oct 29, 2024

Revenue Reached RMB10,461 Million in the Third Quarter,Excluding COVID-19 Commercial Projects,Up 14.6% Year-over-Year

I-Mab to Participate at the Truist Securities BioPharma Symposium

Oct 29, 2024

ROCKVILLE,Md.,Oct. 28,2024--I-Mab (NASDAQ: IMAB),a US-based,global,biotech company,exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer,today an

Trip.Biz Unveils New Product Matrix to Digitalise Business Travel for the Japanese Market

Oct 29, 2024

TOKYO,Oct. 28,2024-- Trip.com Group\'s corporate travel management brand,Trip.Biz,recently hosted its annual conference,\'Trip.Biz Transform 2024,\' in Singapore. The event convened approximately 200

TeleVox Applauded by Frost & Sullivan for Improving Patient Experience through Effective Engagement and Customer Value

Oct 29, 2024

TeleVox\'s highly flexible platform provides PRM capabilities covering the full extent of healthcare stakeholders,enhancing the patient population experience,decreasing missed appointments,and facilit

INEOS STYROLUTION'S POST-CONSUMER RECYCLED POLYSTYRENE SELECTED BY NAM NGAI HONG

Oct 29, 2024

Selected material: Styrolution® PS ECO 260 MR85. Finished products are certified by the Thailand Greenhouse Gas Management Organization as "circular economy" products.

Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK's AREXVY

Oct 29, 2024

-- Head-to-head clinical results indicate a potential best-in-class combined efficacy & safety profile of non-adjuvanted bivalent RSV vaccine candidate (SCB-1019) --

1 ... 247 248 249 250 251 252 253 ... 347